This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Ausgewählte Literatur
Publikationen
Bodmann KF, Vogel F (2002) Sichere parenterale Antibiotikatherapie mit geringen (Folge)Kosten. Klinikarzt 31:3–11
Braveny I, Maschmeyer G (2002) Infektionskrankheiten, 1. Aufl. medco, München
Brodt HR (2006) Tigecyclin (Tygacil). Antibiotika- Glycylcycline. Neue Arzneistoffe 1:58–63
Classen et al (1992) The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. New Engl J Med 326:281–286
Cleary JD et al. (2012) Itraconazol induces changes in cardiac function. ICAAC M–991
Cornely OA, Maertens J, Winston DJ et al (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356:348–359
Courtney R et al. (2003) Pharmakokinetics, safety, and tolerability of oral posaconazole administered in single and multiple diseases in healthy adults. Agents Chemother 47: 2788–2795
Daschner F (2004) Antibiotika am Krankenbett, 12. Aufl. Springer, Berlin Heidelberg New York Tokio
De Jonge E (2003) Effect of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362:1011–1016
De La Cal MA, , Cerdá E, , García-Hierro P et al. (2005) Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial. Ann Surg 241:424–30
de Smet AM et al. (2011) Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. Lancet Infect Dis [Epub ahead of print]
De Smet AMGA, , Kluytmans JAJW, , Cooper BS, et al. (2009) Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med;360:20–31
Ebner et al (2000) Evidenzbasierte Empfehlungen zur perioperativen Antibiotikaprophylaxe. Chirurg 71:912–917
Empfehlungen derE»ParenteraleAderPEG (1999) Parenterale Antibiotika bei Erwachsenen. Chemother J 8:2–49
Empfehlungen einer Expertenkommission der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V (2002) Rationaler Einsatz oraler Antibiotika in der Praxis. Chemother J 11:47–58
Fachinfo NOXAFIL, Essex Pharma 10/2005
Fridkin SK et al (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. NEJM 352:1436–1444
Glöckner A (2011) Innovative Antimykotika zur Therapie invasiver Pilzinfektionen. Internist (Berl) 52:1118–1126
Hao B, Cheng S, Clancy C (2012) Caspofungin induces apoptosis of candioda albicans at < minimum inhibitory concentration. ICAAC M–978
Heininger A, Meyer E, Schwab F, Marschall M, Unertl K, Krüger WA (2006) Effects of long-term routine use of selective digestive decontamination of antimicrobial resistance. Intensive Care Med 31:1569–1576
Heinzman WR et al. (2003/2004) Vademecum Infektiologie, 1. Aufl. Wyeth Pharma, Münster
Hoc S (2005) Antibiotika-Therapie. Multiresistente Erreger im klinischen Alltag. Dtsch Ärztebl 26: A 1905
Ibrahim et al (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155
Keating GM (2005) Posaconazole. Drug 65:1553–1567
King ST et al. (2012) Disruption of candida albicans mitochondrial function by caspofungin. ICAAC M–968
Kollef MH et al (1999) Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 115:462–474
Krüger W et al. (2002) Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions and mortality in critically ill surgical patients: A prospective, stratified, randomized, double blind, placebo-controlled clinical trial. Am J Respir Crit Care Med 166:1029–1037
Leone M et al (2003) Long-term (6-year) effect of selective digestive decontamination on antimicrobial resistance in intensive care, multiple-trauma patients. Crit Care Med 31:2239–2240
Luiten EJ et al (1995) Controlled clinical trial of selective decontamination for the treatment of severe acute pancretaitis. Ann Surg 222:57–65
Luna A et al (1997) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111:676–685
Muralidharan G et al (2005) Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. Antimicrob Agents Chemother 49:220–229
Naber KG, Vogel F, Scholz H, die Expertengruppe der PEG (1998) Rationaler Einsatz oraler Antibiotika in der Praxis. Chemother J 7:16–26
Nathens AB, Marshall JC (1999) Selective decontamination of the digestive tract in surgical patients. Arch Surg 134:170–176
PEG-Empfehlung (1999) Einteilung der oralen Cephalosporine. Chemother J 6:227–229
Quintel M (Hrsg) (2003) Infektionskrankheiten in der Intensivmedizin, 1. Aufl. Uni-Med, Bremen
Reboli AC, Rotstein C, Pappas PG et al (2007) Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356:2472–2482
Rello J et al (1997) The value of routine microbial investigation in ventilator-associated Pneumonia. Am J Respir Crit Care Med 156:196–200
Roilides E, Walsh TJ (2010) Invasive fungal infections in paediatric patients. Clin Microbiol Infect 2010 Sep;16(9):1319–1320
Sandiumenge A et al (2003) Therapy of ventilator-associated pneumonia. Int Care Med 29:876–883
Scholz et al. (1999) Einteilung der Oralcephalosporine. PEG Heft 6
Silvestri L, van Saene HK, Milanese M, Gregori D, Gullo A (2007) Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials. J Hosp Infect 65:187–203
Stille W, Brodt HR, Groll Ah, Just-Nübling G (2005) Antibiotikatherapie. Klinik und Praxis der antiinfektiösen Behandlung, 11. Aufl. Schattauer, Stuttgart
Thalhammer F, Grabein B (2003) Kompendium der antimikrobiellen Therapie, 1. Aufl. Arcis, München
Tsiodras S et al (2001) Linezolid resistance in a clinical isolate of Staphylococcus aureus. The Lancet 358:207–208
Ullmann AJ, Lipton JH, Vesole DH et al (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356:335–347
van Nieuwenhoven CA, Buskens E, van Tiel FH, Bonten MJM (2001) Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients. JAMA 286:335–340
Vogel F, Bodmann K-F und die Expertenkommission der Paul-Ehrlich-Gesellschaft (2004) Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen. Chemother J 4:46–105
Zhanel GG et al (2004) The Glycylcyclines. A comparative review with the tetracyclines. Drugs 64:63–88
Internetadressen
Robert-Koch-Institut: http://www.rki.de
Resistenzkarte: http://www.ecdc.europa.eu
Dosierung: http://www.dosing.de
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fresenius, M. (2014). Antibiotika und Antimykotika. In: Repetitorium Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-44933-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-44933-8_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-44932-1
Online ISBN: 978-3-642-44933-8
eBook Packages: Medicine (German Language)